RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Inhibitory Effect of an N-terminal Recombinant Fragment of Human Thrombospondin-2 on Migration of Human Dermal Microvascular Endothelial Cells = 사람 Thrombospondin-2 단백 아미노 말단 절편의 사람 피부 미세혈관 내피세포 이동 억제 효과

      한글로보기

      https://www.riss.kr/link?id=A19579497

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Thrombospondin-2(TSP-2) has been known to modulate tumor growth, wound healing, and inflammation through inhibition of angiogenesis based on the findings from TSP-2 knock-out mice and overexpression studies. However, the molecular mechanisms of human TSP-2(hTSP-2) for inhibition of angiogenesis or the feasibility to develope as a new therapeutic angiogenesis inhibitor for curing cancer have not been intensively studied because so far the whole molecule of hTSP-2 is not available due to difficulties in extraction of useful amount of hTSP-2 from tissues and limitations on production of full length recombinant hTSP-2 in mammalian or insect cells. Therefore, an N-terminal 80 kDa fragment of hTSP-2 encompassing N-terminal globular region through typeⅠ repeats(hTSP-2/NTF) was expressed in human embryonal kidney 293 EBNA cells to investigate whether this fragment has antiangiogenic effect on primary cultured human endothelial cells(ECs). The recombinant vector was constructed as follows: an 1.67 kbp of cDNA of hTSP-2(nt 213 to 1883) was amplified by PCR from human placenta cDNA library and ligated into KpnⅠ and Bgl Ⅱ sites of the modified pCEP 4 expression vector. The recombinant protein was purified from the serum fee conditioned medium of transfected 293 EBNA cells using ammonium sulfate precipitation and gelatin- and heparin-sepharose columns. Yield was 2.1 ㎎/l of conditioned medium and the purified protein was confirmed by N-terminal peptide sequencing. To see the fragment has anti-angiogenic activity in vitro, migration assay was performed on human dermal microvascular ECs(HDMECs) with the recombinant protein, demonstrating inhibition of migration by 30 % at 1 ㎎/ml of hTSP-2/NTF as compared to control group. This effect was not neutralized by anti-CD 36 antibody, suggesting a different receptor other than CD 36, to which TSP-1 binds and inhibits EC migration, may be involved in the inhibitory mechanism of hTSP-2/NTF on the migration of HDMECs. Futher study to see in vivo antiangiogenic activity of hTSP-2/NTF is on-going to evaluate the validity of this fragment as a new antiangiogenic agent.
      번역하기

      Thrombospondin-2(TSP-2) has been known to modulate tumor growth, wound healing, and inflammation through inhibition of angiogenesis based on the findings from TSP-2 knock-out mice and overexpression studies. However, the molecular mechanisms of human ...

      Thrombospondin-2(TSP-2) has been known to modulate tumor growth, wound healing, and inflammation through inhibition of angiogenesis based on the findings from TSP-2 knock-out mice and overexpression studies. However, the molecular mechanisms of human TSP-2(hTSP-2) for inhibition of angiogenesis or the feasibility to develope as a new therapeutic angiogenesis inhibitor for curing cancer have not been intensively studied because so far the whole molecule of hTSP-2 is not available due to difficulties in extraction of useful amount of hTSP-2 from tissues and limitations on production of full length recombinant hTSP-2 in mammalian or insect cells. Therefore, an N-terminal 80 kDa fragment of hTSP-2 encompassing N-terminal globular region through typeⅠ repeats(hTSP-2/NTF) was expressed in human embryonal kidney 293 EBNA cells to investigate whether this fragment has antiangiogenic effect on primary cultured human endothelial cells(ECs). The recombinant vector was constructed as follows: an 1.67 kbp of cDNA of hTSP-2(nt 213 to 1883) was amplified by PCR from human placenta cDNA library and ligated into KpnⅠ and Bgl Ⅱ sites of the modified pCEP 4 expression vector. The recombinant protein was purified from the serum fee conditioned medium of transfected 293 EBNA cells using ammonium sulfate precipitation and gelatin- and heparin-sepharose columns. Yield was 2.1 ㎎/l of conditioned medium and the purified protein was confirmed by N-terminal peptide sequencing. To see the fragment has anti-angiogenic activity in vitro, migration assay was performed on human dermal microvascular ECs(HDMECs) with the recombinant protein, demonstrating inhibition of migration by 30 % at 1 ㎎/ml of hTSP-2/NTF as compared to control group. This effect was not neutralized by anti-CD 36 antibody, suggesting a different receptor other than CD 36, to which TSP-1 binds and inhibits EC migration, may be involved in the inhibitory mechanism of hTSP-2/NTF on the migration of HDMECs. Futher study to see in vivo antiangiogenic activity of hTSP-2/NTF is on-going to evaluate the validity of this fragment as a new antiangiogenic agent.

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼